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Monensin is approved as a feed additive by the FDA Center for Veterinary Medicine to increase 
milk production efficiency in lactating dairy cattle. To assess the effects of a gross error in 
mixing monensin into cattle feed, a 10-fold overdose was given for three consecutive days to 
naïve cows as well as cows previously dosed with monensin within the label range. Cows were 
evaluated during the overdose and for a subsequent 4 week observation period. Physiological 
variables were analyzed, including dry matter intake, body weight, body condition score, and 
serum chemistry profile. Production variables were analyzed, including milk yield and milk 
composition. Cows were blocked according to pre-treatment milk output, days in milk, and body 
condition.  Results were analyzed using linear mixed model methodology with a baseline 
covariate.  The study provided information for the veterinarian and the dairy farmer for 
determining whether an overdose may have occurred, for assessing the prognosis, and for 




The overdose study was designed to examine the effects of a monensin overdose which 
might occur on a farm.  Since monensin is provided to dairy cattle in their feed, an overdose 
could result from a mixing error. One of the goals of the study was to determine what signs the 
veterinarian and the farmer should expect if an overdose does occur.  If there was another cause 
for health problems in a herd, this information could also help to rule out an overdose, and 
enable the veterinarians and farmers to identify the true problem more quickly.  A second goal 
was to determine whether there was any difference in the recovery from an overdose between 
animals previously acclimated to monensin and naïve animals. Another goal was to assess 
whether it is better, after an overdose, to continue feeding the cows monensin (at the intended 
dose) or feed them unmedicated feed, and to determine if that answer depends on whether the 
animal was on monensin prior to the overdose. 
 
2. STUDY DESIGN 
The overdose study was conducted at the Elanco facilities in Greenfield, Indiana.  The 
study included 22 multiparous cows in the second, third, or fourth lactation.  Animals in the 
study were previously on an inclusion study to test for effects of sudden inclusion of monensin 
112 Kansas State University




into diets during lactation.  During the inclusion study, half of the animals were fed monensin at 
24 ppm (the high end of the approved dose range) and the other half received no monensin.  By 
scheduling the overdose study immediately follow the inclusion study, the effects of an overdose 
on cows currently on monensin treatment and also on naïve cows could be determined. 
During the overdose, all cows received 240 ppm monensin (a 10-fold overdose of the 
high end of the approved dose range) in their feed.  Following the overdose, half of the cows in 
each of the inclusion dose groups were given 24 ppm monensin and half were given no 
monensin. This allocation resulted in a factorial treatment design (Table 1) with the two levels of 
Inclusion Dose (0 and 24 ppm) crossed with the two levels of Recovery Dose (0 and 24 ppm). 
A randomized complete block design was used, with blocking based on milk yield, days 
in milk (number of days into the lactation), and body condition score, at the beginning of the 
inclusion study. There were 5 complete blocks in which each of the Inclusion Dose by Recovery 
Dose combinations was represented, and one block with only two cows and two of the 
combinations represented.  The cows were grouped into blocks such that all cows within a block 
had relatively similar levels for all of these variables, with milk yield handled as the most 
important of these factors. 
 
3. DATA COLLECTED 
Physiological and production variables were collected for analyses.  The measurements 
were taken at various frequencies. Dry Matter Intake was measured daily. Body Condition Score, 
Body Weight, and Blood Chemistry were each measured at several specific timepoints 
throughout the study. Milk yield was measured daily, and milk composition was assessed 3 times 
per week.  Only a subset of the data is presented here. 
 
4. DATA ANALYSIS AND RESULTS 
The study was divided into three phases for analysis.  The first phase was the Overdose, 
which lasted for 3 days.  The second phase was the Acute Recovery phase, defined as the 4 days 
following the overdose, and the third phase was the Chronic Recovery phase, defined as the 
subsequent 3-week period. 
 
4.1 Overdose 
During the three-day Overdose phase, all cows received the same dosage of monensin. 
The treatment difference analyzed for this phase was that half of the cows were previously dosed 
with monensin and half of the cows were unexposed.  Therefore, the treatment effect that was 
being assessed during the Overdose phase was a treatment applied prior to the overdose. 
The statistical model for the Overdose phase is given in Equation 1.  A linear mixed 
model analysis was performed using SAS® Proc Mixed.  Baseline values, collected for the 
variables during the week prior to the overdose, were used as covariates. The covariate and the 
dose (0 or 24 ppm monensin) given in the inclusion study were fixed effects in all models.   The 
effects involving day (Day and the Dose*Day interaction) were included for those variables 
measured at multiple timepoints during the Overdose phase.  Random effects included Block, 
Inclusion Dose by Block Interaction (since there were two cows per treatment group per 
complete block during the Overdose phase), and for those variables measured at multiple 
timepoints, Cow(Block).  Standard normality assumptions were made regarding all random 
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effects.  Specifically, the levels of each random effect are independent identically-distributed 
normal random variables with a zero mean, and each random effect is independent of the others.  
The random effects created a compound symmetry covariance structure for analysis of variables 
measured at multiple timepoints.  Because the error terms were linear combinations of variance 
components, the denominator degrees of freedom were calculated using the Satterthwaite 
approximation (1).   
 
ijkllijlljkkjiijkl BcBBXXY εααδδαλµ +++++++−+= )()(   (1) 
 
  = response value ijklY
 
Fixed effects 
µ  overall mean 
λ  Baseline coefficient ( = baseline measurement) iX
jα  Inclusion Dose  
kδ  Day  
jkαδ  Inclusion Dose*Day 
 
Random effects 
lB  Block  
jlBα  Inclusion Dose*Block  
)( li Bc  Cow(Block)  
ijklε  Residual Error  
 
An alpha level of 0.05 was used for all statistical tests.  The 0 and 24 ppm monensin Inclusion 
Dose treatment groups were compared across the entire Overdose phase. For variables where 
multiple measurements were collected during the phase, the Day and Dose by Day interaction 
were assessed over the entire phase.  Additionally, for those variables where multiple 
measurements were collected, linear contrasts comparing doses were presented at each 
timepoint, regardless of overall significant differences.  For example, 
 
0: =− BtAtH µµo       vs.     0: ≠−Α BtAtH µµ     (2) 
 
where t=indicates a given timepoint, A and B indicate Inclusion Dose treatment groups, and µ is 
the cell mean for the indicated treatment group and time.  Although numerous response variables 
were analyzed and several tests calculated for most of the variables, no multiple comparison 
adjustments were used, since this was a safety study and it was important to identify all possible 
effects.  
The baseline covariate was included in the model to adjust for between-animal variation. 
Additionally, since animals were previously on different treatments, there were substantial pre-
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existing differences between treatment groups in some of the variables to be measured.  
Normally, one would collect the covariate measurements prior to administering treatment. 
However, in this study, the interest was in assessing the differential change following an 
overdose between cows previously treated with monensin and cows which were unexposed.  
That is, the goal was to determine how the response variables changed for one group of cows 
following the overdose, compared to the other group of cows.  
The daily dry matter intake (DMI) raw means are shown in Figure 1, plotted by the 
Inclusion Dose over the entire study, beginning with the baseline period. The Overdose phase is 
bracketed by vertical lines. This graph demonstrates the first sign of the overdose, which was a 
dramatic decrease in feed intake within 24 hours. The feed intake continued to decrease during 
the three day Overdose phase. The animals in the 0 ppm Inclusion Dose group had slightly 
higher DMI before the overdose, but were more severely impacted by the overdose, with their 
intake dropping below that of the 24 ppm Inclusion Dose group animals. 
The statistical analysis of the DMI for the Overdose phase is shown in Table 2. The 
overall effect from the Inclusion Dose was significant (P=0.008), as was the effect of Day 
(P<0.001). The baseline-adjusted least squares means show that the immediate drop in DMI was 
less severe for cows previously acclimated to monensin (P=0.003 and 0.012 for Day 1 and Day 
2, respectively).  However, by Day 3 of the overdose, DMI values were not different between the 
two groups (P=0.692). 
 
4.2 Recovery  
The data from the Acute Recovery phase (the four days following the overdose) and the 
Chronic Recovery phase (the subsequent three weeks) were analyzed separately. The analyses 
for Acute Recovery used daily response values, whereas the analyses for Chronic Recovery used 
weekly averages. 
The analyses for both Recovery phases implemented the same statistical model, shown in 
Equation 3. Fixed effects included a baseline covariate, Inclusion Dose, Recovery Dose, and the 
interaction. For those variables measured at multiple timepoints, the effect for time (either Day 
or Week) and the related interactions were also included.  Random effects were Block, and for 
those variables measured at multiple timepoints, Cow(Block).  There were no interaction terms 
for the Dose effects with Block since there was only one cow per treatment combination in each 
block during Recovery.  Standard normality assumptions were made regarding all random 
effects.  Specifically, the levels of each random effect are independent identically-distributed 
normal random variables with a zero mean, and each random effect is independent of the others.  
The random effects created a compound symmetry covariance structure for analysis of variables 
measured at multiple timepoints.  Because the error terms were linear combinations of variance 
components, the denominator degrees of freedom were calculated using the Satterthwaite 
approximation (1).   
 
ijklmmimjklkljlljkkjiijklm BcBXXY εαβτβτατταββαλµ ++++++++++−+= )()(  (3) 
 
 = response value ijklmY
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µ  overall mean 
λ  Baseline coefficient ( iX  = baseline measurement) 
jα  Inclusion Dose 
kβ  Recovery Dose  
jkαβ  Inclusion Dose*Recovery Dose 
lτ  Time 
jlατ  Inclusion Dose*Time 
klβτ  Recovery Dose*Time 
jklαβτ  Inclusion Dose*Recovery Dose*Time 
 
Random effects 
mB   Block  
)( mi Bc Cow(Block)  
ijklmε  residual error 
 
An alpha level of 0.05 was used for all statistical tests.  The dose effects were analyzed 
across each phase. For variables where multiple measurements were collected, the Time and 
Dose by Time interaction effects were assessed across the phase. Linear contrasts comparing 
dose main effects and interactions were also tested at each timepoint, for those variables.  For 
example,  
 
       Inclusion Dose Effect 0: =− •• tBtAH µµo       vs.     0: ≠− ••Α tBtAH µµ   (4) 
 
       Recovery Dose Effect 0: =− •• BtAtH µµo       vs.     0: ≠− ••Α BtAtH µµ   (5) 
 
       Inclusion by Recovery Dose Effect 
0)()(: =−−− BBtABtBAtAAtH µµµµo       vs.      
0)()(: ≠−−− BBtABtBAtAAtAH µµµµ    (6) 
 
where t=indicates a given timepoint, A and B indicate treatment groups for the Inclusion Dose 
[in the first subscript position] or for the Recovery Dose [in the second subscript position], and 
µ  is the cell mean and µ  is the marginal mean for the indicated treatment group and time. 
For DMI during the Acute Recovery phase, no interaction was detected in the overall 
tests (p-values ≥0.263, Table 3).  However, the Inclusion Dose and Day were both significant (p-
values <0.001) and there was weak evidence (P=0.109) for a Recovery Dose effect.  Contrasts 
for individual days showed that the Inclusion Dose effect was significant (p-values ≤0.001) for 
all four days.  The least squares means showed that the baseline-adjusted DMI for the monensin-
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acclimated cows (24 ppm Inclusion Dose) continued to be higher than those of the naïve cows 
throughout the Acute Recovery phase. The Recovery Dose effect was not significant in the daily 
contrasts (p-values ≥0.077).  
For DMI during the Chronic Recovery phase, there were no significant interactions in the 
overall tests (p-values ≥0.349, Table 4). The Inclusion Dose effect and the Week effect were 
significant (P=0.009 and P=0.028, respectively), but the Recovery dose had little impact 
(P=0.727). Contrasts indicate Inclusion Dose differences exist by week during Weeks 2 and 3 
Relative to Overdose (P=0.012 and P=0.015, respectively).  As shown by the least squares means 
for the Inclusion Dose, the cows previously acclimated to monensin had higher baseline-adjusted 
DMI than naïve cows. 
As with DMI, the Recovery Dose had little impact on most response variables tested. 
However, in a few cases such as the milk fat percent during the Acute Recovery phase, the 
Recovery Dose effect was significant (P=0.030, Table 5).  Although the milk fat percent dropped 
following the overdose, the cows which were fed monensin after the overdose had less of a drop 
than those cows which were fed unmedicated feed. Additionally, the cows which were 
acclimated to monensin before the overdose had higher baseline-adjusted milk fat percent than 
naïve animals (P=0.011). 
 
5. SUMMARY 
The first alteration observed following the monensin overdose in lactating dairy cows 
was a reduction in dry matter intake by over 25% the first day.  By the third day of the overdose, 
the cows were eating only approximately half of their pre-overdose feed amounts. Such a 
dramatic reduction in feed intake would indicate to a veterinarian or farmer that an overdose may 
have occurred.  
Cows previously acclimated to monensin did not have as dramatic or rapid a decrease in 
dry matter intake during the overdose as did the naïve cows.  The monensin-acclimated cows 
also recovered from the overdose more quickly.  Similarly, monensin-acclimated cows 
experienced lesser effects from the overdose for many of the other physiological and production 
variables tested.  Feeding the cows 0 vs 24 ppm monensin following the overdose had little 
impact on dry matter intake or most of the other response variables analyzed. 
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Table 1.  Treatment Design 









0 240 0 6 
0 240 24 5 
24 240 0 5 
24 240 24 6 
 
 
Figure 1.  Daily Dry Matter Intake Raw Means by Inclusion Dose Group 
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Table 2.  Daily Dry Matter Intake (kg/day) Analysis 
Overdose Phase 
         
Inclusion   Day Relative to   
Dose    Start of Overdose   
ppm Stat Baseline 1 2 3 Average 
0 LSMean 26.5 17.3 13.6 13.5 14.8   
     
24 LSMean 25.5 20.1 15.8 13.9 16.6  
     
 P-value 0.003 0.012 0.692   
       
         
Source     P-value       
Dose   0.008     
Day   <0.001     
Dose * Day   0.108          
Dose indicates the Inclusion Dose. 
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Table 3.  Daily Dry Matter Intake (kg/day) Analysis 
Acute Recovery Phase 
          
IDose RDose    Day Relative to Start of Overdose  
ppm ppm Stat Baseline 4 5 6 7 Average
0 0 LSMean 26.3 16.8 18.7 18.7 20.4 18.7
0 24 LSMean 26.7 17.0 18.3 18.7 19.8 18.4
24 0 LSMean 25.2 19.6 21.8 22.8 23.2 21.8
24 24 LSMean 25.7 18.9 20.6 20.4 22.8 20.7
  Main Effects         
0  LSMean 26.5 16.9 18.5 18.7 20.1 18.5
24  LSMean 25.5 19.2 21.2 21.6 23.0 21.2
    
 0 LSMean 25.8 18.2 20.2 20.7 21.8 20.3
 24 LSMean 26.2 17.9 19.4 19.5 21.3 19.5
  Idose P-value   0.001 <0.001 <0.001 <0.001  
  Rdose P-value  0.691 0.252 0.077 0.435 
  IDose*Rdose P-value  0.535 0.582 0.089 0.939 
     
Analysis of Variance P-value      
IDose   <0.001      
RDose   0.109      
Day   <0.001      
IDose * RDose  0.263      
IDose * Day  0.909      
RDose * Day  0.735      
IDose * RDose * Day 0.574      
IDose indicates Inclusion Dose.  
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Table 4.  Daily Dry Matter Intake (kg/day) Analysis 
Chronic Recovery Phase 
      
Week 
Relative 
to   
IDose RDose   Start of Overdose  
ppm ppm Stat Baseline 2 3 4 Average 
0 0 LSMean 26.3 23.6 22.6 22.4 22.9
0 24 LSMean 26.7 23.4 23.1 23.1 23.2
24 0 LSMean 25.2 25.4 25.0 24.4 24.9
24 24 LSMean 25.7 25.0 24.1 23.6 24.3
  Main Effects       
0  LSMean 26.5 23.5 22.8 22.7 23.0
24  LSMean 25.5 25.2 24.5 24.0 24.6
    
 0 LSMean 25.8 24.5 23.8 23.4 23.9
 24 LSMean 26.2 24.2 23.6 23.3 23.7
  Idose P-value  0.012 0.015 0.062  
  Rdose P-value 0.617 0.815 0.936 
  IDose*Rdose P-value 0.912 0.292 0.293 
    
Analysis of Variance   P-value    
IDose    0.009     
RDose    0.727     
Week    0.028     
IDose * RDose   0.349     
IDose * Week   0.768     
RDose * Week   0.927     
IDose * RDose * Week  0.607     
IDose indicates Inclusion Dose.  
RDose indicates Recovery Dose. 
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Table 5.  Milk Fat Percent Analysis 
Acute Recovery Phase 
IDose RDose   
Day Relative to Start of 
Overdose 
ppm ppm Stat Baseline 4 7 Average 
0 0 LSMean 3.64 2.65 2.02 2.33 
0 24 LSMean 3.53 2.64 2.11 2.37 
24 0 LSMean 3.48 2.84 2.02 2.43 
24 24 LSMean 3.34 3.33 2.42 2.88 
  Main Effects       
0  LSMean 3.58 2.64 2.07 2.35 
24  LSMean 3.41 3.08 2.22 2.65 
    
 0 LSMean 3.56 2.74 2.02 2.38 
 24 LSMean 3.44 2.98 2.27 2.63 
  Idose P-value    0.002 0.251   
  Rdose P-value   0.077 0.077  
  IDose*Rdose P-value  0.068 0.259  
  
Analysis of Variance    P-value   
IDose     0.011  
RDose     0.030  
Day     <0.001  
IDose * RDose    0.064  
IDose * Day    0.122  
RDose * Day    0.979  
IDose * RDose * Day   0.599  
IDose indicates Inclusion Dose.  
RDose indicates Recovery Dose. 
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